LYMPHIR Trademark

Trademark Overview

On Tuesday, April 4, 2023, a trademark application was filed for LYMPHIR with the United States Patent and Trademark Office. The USPTO has given the LYMPHIR trademark a serial number of 97871965. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, April 3, 2026. This trademark is owned by Citius Pharmaceuticals, Inc.. The LYMPHIR trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; Pharmaceutical products for the treatment of cancer
lymphir

General Information

Serial Number97871965
Word MarkLYMPHIR
Filing DateTuesday, April 4, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, April 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements

Goods and ServicesAnti-cancer preparations; Pharmaceutical products for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 10, 2023
Primary Code005
First Use Anywhere DateMonday, November 24, 2025
First Use In Commerce DateMonday, November 24, 2025

Trademark Owner History

Party NameCITIUS ONCOLOGY, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCRANFORD, NJ 07016
US
Party NameCitius Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranford, NJ 07016
US
Party NameCitius Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranford, NJ 07016
US

Trademark Events

Event DateEvent Description
Friday, April 7, 2023NEW APPLICATION ENTERED
Monday, April 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 30, 2023ASSIGNED TO EXAMINER
Sunday, December 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 2, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 20, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 2, 2024SOU EXTENSION 1 FILED
Wednesday, November 20, 2024SOU EXTENSION 1 GRANTED
Wednesday, November 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 10, 2025SOU TEAS EXTENSION RECEIVED
Monday, February 10, 2025SOU EXTENSION 2 FILED
Tuesday, February 11, 2025SOU EXTENSION 2 GRANTED
Tuesday, February 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 29, 2025SOU TEAS EXTENSION RECEIVED
Monday, September 29, 2025SOU EXTENSION 3 FILED
Monday, September 29, 2025SOU EXTENSION 3 GRANTED
Tuesday, September 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 2, 2026TEAS STATEMENT OF USE RECEIVED
Thursday, April 2, 2026USE AMENDMENT FILED
Friday, April 3, 2026STATEMENT OF USE PROCESSING COMPLETE
Friday, April 3, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 3, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

lymphir cancer treatment products preparations anti pharmaceutical